5,5-Diphenylhydantoin
SIGMA/D4007 - ≥98%
Synonym: 5,5-
CAS Number: 57-41-0
Empirical Formula (Hill Notation): C15H12N2O2
Molecular Weight: 252.27
EC Number: 200-328-6
MDL Number: MFCD00005264
Linear Formula: C15H12N2O2
Product Type: Chemical
| assay | ≥98% |
| form | powder |
| InChI | 1S/C15H12N2O2/c18-13-15(1 |
| InChI key | CXOFVDLJLONNDW-UHFFFAOYSA |
| mp | 293-295 °C (lit.) |
| Quality Level | 100 ![]() |
| SMILES string | O=C1NC(=O)C(N1)(c2ccccc2) |
| solubility | DMSO: soluble |
| Application: | 5,5-Diphenylhydantoin has been used for phenytoin treatment. It has also been used to slow down or prevent mesoendoderm cell migration. |
| Biochem/physiol Actions: | Anticonvulsant. |
| Biochem/physiol Actions: | Reduces incidence of grand mal seizures; appears to stabilize excitable membranes perhaps through effects on Na+, K+, and Ca2+ channels. |
| General description: | 5,5-Diphenylhydantoin is an anticonvulsant, which is used to treat tonic-clonic seizures, complex partial seizures and neurosurgical related seizures. It induces osteoblast proliferation and differentiation. 5,5-Diphenylhydantoin used to treat epilepsy. It reduces the hyperexcitability of tissues and may be associated with cerebellar atrophy. |
| Packaging: | 5, 100 g in poly bottle |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Danger |
| Hazard statements | H302 - H351 - H360FD |
| Precautionary statements | P202 - P264 - P270 - P280 - P301 + P312 - P308 + P313 |
| Hazard Codes | T |
| Risk Statements | 45-61-22 |
| Safety Statements | 53-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | ≥98% |
| mp | 293-295 °C (lit.) |
| UNSPSC | 12352200 |



